Tom Bersot

Tom Bersot is a Professor in the Department of Medicine at the University of California, San Francisco (UCSF) School of Medicine. He maintains an active research profile with a focus on dyslipidemia, metabolic syndrome, lipoprotein biology, and cardiometabolic risk factors, particularly in Turkish populations.

His research spans genetic and metabolic studies of lipid disorders, including collaborations on genome-wide association analyses (GEMS Study), inflammatory markers in dyslipidemia, and clinical guidelines for managing dyslipidemia. Notably, he co-authored executive summaries for the International Society of Atherosclerosis on global dyslipidemia treatment recommendations.

His publications (2015–2003) reveal trends in studying dietary impacts on lipogenesis, HDL characterization, and Turkish population-specific lipid abnormalities. Key themes include genetic variants affecting lipid metabolism, macrophage lipid accumulation, and anthropometric indices for cardiometabolic risk.

Scientific awards include participation in international dyslipidemia guideline panels. His work has influenced clinical practices for atherogenic dyslipidemia and metabolic syndrome diagnosis, particularly through comparative studies of Turkish and global populations.